Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high‐dose chemotherapy and autologous stem cell transplantation for lymphoma
Isabell Ge; Rima M. Saliba; Farzaneh Maadani; Uday R. Popat; Muzaffar H. Qazilbash; Sai Ravi Pingali; Nina Shah; Sairah Ahmed; Qaiser Bashir; Yago Nieto; Richard E. Champlin; Chitra Hosing
Author Information: Department of Gynecology and Obstetrics
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.